Board/Management Information • Mar 15, 2023
Board/Management Information
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 15 March 2023 18:30
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
15-March-2023 / 18:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. (SAE.DE), hereby announces that the supervisory board resolved today to propose Mr. Olaf Heinrich for election as member of the managing board and chairman of the managing board of the company at the next annual general meeting, which is expected to be held on 26 April 2023. It is intended that Mr. Olaf Heinrich will take office as a member of the managing board and chairman of the managing board on 1 August 2023 and will already be a consultant to the company in the period from 1 April 2023 to 31 July 2023.
15-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 – 200 800 300 |
| Fax: | 0800 – 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1583653 |
| End of Announcement | EQS News Service |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.